{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T19:15:36Z","timestamp":1787426136326,"version":"build-2736575974"},"reference-count":52,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T00:00:00Z","timestamp":1670198400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI20\/00661, PI14\/00612, PI11\/00325, PI08\/0208"],"award-info":[{"award-number":["PI20\/00661, PI14\/00612, PI11\/00325, PI08\/0208"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>First episode of psychosis (FEP) patients display a wide variety of metabolic disturbances at onset, which might underlie these patients\u2019 increased morbidity and early mortality. Glycemic abnormalities have been previously related to pharmacological agents; however, recent research highlights the impact of early life events. Birth weight (BW), an indirect marker of the fetal environment, has been related to glucose abnormalities in the general population over time. We aim to evaluate if BW correlates with glucose values in a sample of FEP patients treated with different antipsychotics. Two hundred and thirty-six patients were included and evaluated for clinical and metabolic variables at baseline and at 2, 6, 12, and 24 months of follow-up. Pearson correlations and linear mixed model analysis were conducted to analyze the data. Antipsychotic treatment was grouped due to its metabolic risk profile. In our sample of FEP patients, BW was negatively correlated with glucose values at 24 months of follow-up [r=-0.167, p=0.037]. BW showed a trend towards significance in the association with glucose values over the 24-month period (F=3.22; p=0.073) despite other confounders such as age, time, sex, body mass index, antipsychotic type, and chlorpromazine dosage. This finding suggests that BW is involved in the evolution of glucose values over time in a cohort of patients with an FEP, independently of the type of pharmacological agent used in treatment. Our results highlight the importance of early life events in the later metabolic outcome of patients.<\/jats:p>","DOI":"10.3389\/fendo.2022.983792","type":"journal-article","created":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T06:40:00Z","timestamp":1670222400000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["The effect of early life events on glucose levels in first-episode psychosis"],"prefix":"10.3389","volume":"13","author":[{"given":"Clemente","family":"Garcia-Rizo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bibiana","family":"Cabrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miquel","family":"Bioque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gisela","family":"Mezquida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Lobo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Gonzalez-Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Covadonga M.","family":"Diaz-Caneja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iluminada","family":"Corripio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduard","family":"Vieta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inmaculada","family":"Baeza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Paz","family":"Garcia-Portilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Gutierrez-Fraile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Rodriguez-Jimenez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Garriga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio","family":"Fernandez-Egea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Bernardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"PEPs GROUP","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,12,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0195687","article-title":"Prevalence of psychotic disorders and its association with methodological issues. A systematic review and meta-analyses","volume":"13","author":"Moreno-K\u00fcstner","year":"2018","journal-title":"PloS One"},{"key":"B2","volume-title":"The pathology of mind","author":"Maudsley","year":"1879"},{"key":"B3","article-title":"Mood and psychotic disorders and type 2 diabetes: A metabolic triad","volume":"29","author":"McIntyre","year":"2005","journal-title":"Can J Diabetes"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2017.06.032","article-title":"Evolution of metabolic risk factors over a two-year period in a cohort of first episodes of psychosis","volume":"193","author":"Bioque","year":"2016","journal-title":"Schizophr. Res"},{"key":"B5","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/J.EURONEURO.2020.08.009","article-title":"A 3-year prospective study on the metabolic effect of aripiprazole, quetiapine and ziprasidone: A pragmatic clinical trial in first episode psychosis patients","volume":"39","author":"V\u00e1zquez-Bourgon","year":"2020","journal-title":"Eur Neuropsychopharmacol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0055176","article-title":"Excess mortality, causes of death and life expectancy in 270,770 patients with recent onset of mental disorders in Denmark, Finland and Sweden","volume":"8","author":"Nordentoft","year":"2013","journal-title":"PloS One"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.18m12284","article-title":"Exposure to second-generation antipsychotics and risk of type 2 diabetes mellitus in adolescents and young adults: A nationwide study in Taiwan","volume":"80","author":"Tu","year":"2019","journal-title":"J Clin Psychiatry"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e31820fcea3","article-title":"Metabolic effects of olanzapine in patients with newly diagnosed psychosis","volume":"31","author":"Fernandez-Egea","year":"2011","journal-title":"J Clin Psychopharmacol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.schres.2016.09.026","article-title":"Meta-analysis of glucose tolerance, insulin, and insulin resistance in antipsychotic-na\u00efve patients with nonaffective psychosis","volume":"179","author":"Greenhalgh","year":"2017","journal-title":"Schizophr. Res"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2019.0304","article-title":"Association of insulin resistance with schizophrenia polygenic risk score and response to antipsychotic treatment","volume":"76","author":"Tomasik","year":"2019","journal-title":"JAMA Psychiatry"},{"key":"B11","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/acps.12309","article-title":"The thrifty psychiatric phenotype","volume":"131","author":"Garcia-Rizo","year":"2015","journal-title":"Acta Psychiatr Scand"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2020.109910","article-title":"Implications of early life stress on fetal metabolic programming of schizophrenia: A focus on epiphenomena underlying morbidity and early mortality","volume":"101","author":"Garcia-Rizo","year":"2020","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"B13","article-title":"Developmental Origins of Health and Disease","author":"Gluckman","year":"2006"},{"key":"B14","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/BF00400248","article-title":"Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis","volume":"35","author":"Hales","year":"1992","journal-title":"Diabetologia"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2016.02.001","article-title":"Abnormal glycemic homeostasis at the onset of serious mental illnesses: A common pathway","volume":"67","author":"Garcia-Rizo","year":"2016","journal-title":"Psychoneuroendocrinology"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1111\/eip.12749","article-title":"Glucose metabolism dysregulation at the onset of mental illness is not limited to first episode psychosis: A systematic review and meta-analysis","volume":"13","author":"Kucukgoncu","year":"2019","journal-title":"Early Interv. Psychiatry"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.159.7.1080","article-title":"Obstetric complications and schizophrenia: Historical and meta-analytic review","volume":"159","author":"Cannon","year":"2002","journal-title":"Am J Psychiatry"},{"key":"B18","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/S2215-0366(20)30057-2","article-title":"Prenatal and perinatal risk and protective factors for psychosis: a systematic review and meta-analysis","volume":"7","author":"Davies","year":"2020","journal-title":"Lancet Psychiatry"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.118.008870","article-title":"Birth weight and risk of type 2 diabetes mellitus, cardiovascular disease, and hypertension in adults: A meta-analysis of 7 646 267 participants from 135 studies","volume":"7","author":"Knop","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.eurpsy.2019.08.015","article-title":"Birth dimensions, severe mental illness and risk of type 2 diabetes in a cohort of Danish men born in 1953","volume":"62","author":"Garriga","year":"2019","journal-title":"Eur Psychiatry"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2022.108181","article-title":"The association between birth weight, ponderal index, psychotropic medication, and type 2 diabetes in individuals with severe mental illness","volume":"36","author":"Wium-Andersen","year":"2022","journal-title":"J Diabetes Complications"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2019.12.030","article-title":"Birth weight and antipsychotic induced weight gain: A prenatal programming approach in the PEPs study","volume":"218","author":"Garcia-Rizo","year":"2020","journal-title":"Schizophr. Res"},{"key":"B23","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jpsychires.2019.05.004","article-title":"Antipsychotic-induced weight gain and birth weight in psychosis: A fetal programming model","volume":"115","author":"Garriga","year":"2019","journal-title":"J Psychiatr Res"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2016.03.008","article-title":"Association of birth weight and the development of antipsychotic induced adiposity in individuals with treatment resistant schizophrenia","volume":"26","author":"Ziauddeen","year":"2016","journal-title":"Eur Neuropsychopharmacol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2019-001036","article-title":"Birth weight, family history of diabetes and diabetes onset in schizophrenia","volume":"8","author":"Fernandez-Egea","year":"2020","journal-title":"BMJ Open Diabetes Res Care"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.rpsm.2018.10.001","article-title":"CIBERSAM: Ten years of collaborative translational research in mental disorders","volume":"12","author":"Salagre","year":"2019","journal-title":"Rev Psiquiatr. Salud Ment"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2017.01.058","article-title":"Modelling gene-environment interaction in first episodes of psychosis","volume":"189","author":"Bernardo","year":"2017","journal-title":"Schizophr. Res"},{"key":"B28","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.rpsmen.2012.11.001","article-title":"Assessing clinical and functional outcomes in a gene\u2013environment interaction study in first episode of psychosis (PEPs)","volume":"6","author":"Bernardo","year":"2013","journal-title":"Rev Psiquiatr. y Salud Ment (English Ed"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2009.09060802","article-title":"International consensus study of antipsychotic dosing","volume":"167","author":"Gardner","year":"2010","journal-title":"Am J Psychiatry"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1177\/0269881116645254","article-title":"BAP guidelines on the management of weight gain, metabolic disturbances and cardiovascular risk associated with psychosis and antipsychotic drug treatment","volume":"30","author":"Cooper","year":"2016","journal-title":"J Psychopharmacol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyv121","article-title":"A pharmacovigilance study in first episode of psychosis: Psychopharmacological interventions and safety profiles in the PEPs project","volume":"19","author":"Bioque","year":"2016","journal-title":"Int J Neuropsychopharmacol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.61.3.310","article-title":"Move over ANOVA: Progress in analyzing repeated-measures data and its reflection in papers published in the archives of general psychiatry","volume":"61","author":"Gueorguieva","year":"2004","journal-title":"Arch Gen Psychiatry"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/J.RPSM.2022.05.003","article-title":"Metabolic syndrome and related factors in a large sample of antipsychotic na\u00efve patients with first-episode psychosis: 3 years follow-up results from the PAFIP cohort","author":"Garrido-Torres","year":"2022","journal-title":"Rev Psiquiatr. Salud Ment"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.281.6250.1253","article-title":"Ultrasound evidence of sexual difference in fetal size in first trimester","volume":"281","author":"Pedersen","year":"1980","journal-title":"BMJ"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2019.07.002","article-title":"Maternal cortisol during pregnancy and offspring schizophrenia: Influence of fetal sex and timing of exposure. Schizophr","volume":"213","author":"Ellman","year":"2019","journal-title":"Res"},{"key":"B36","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s00787-016-0866-x","article-title":"The effects of antipsychotics on weight gain, weight-related hormones and homocysteine in children and adolescents: a 1-year follow-up study","volume":"26","author":"Baeza","year":"2017","journal-title":"Eur Child Adolesc. Psychiatry"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1177\/0706743718762097","article-title":"Social determinants of health and preclinical glycemic control in newly diagnosed first-episode psychosis patients","volume":"63","author":"Veru-Lesmes","year":"2018","journal-title":"Can J Psychiatry"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2019.104536","article-title":"Childhood trauma and glucose metabolism in patients with first-episode psychosis","volume":"113","author":"Tosato","year":"2020","journal-title":"Psychoneuroendocrinology"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1097\/NMD.0000000000000897","article-title":"Obstetric phenotypes in the heterogeneity of schizophrenia","volume":"206","author":"Mezquida","year":"2018","journal-title":"J Nerv Ment Dis"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.4274\/jcrpe.galenos.2020.2020.0070","article-title":"Methylation status of glp2r, lep and irs2 in small for gestational age children with and without catch-up growth","volume":"13","author":"Angulo","year":"2021","journal-title":"JCRPE J Clin Res Pediatr Endocrinol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1017\/S2040174417000800","article-title":"Associations between maternal prenatal stress, methylation changes in IGF1 and IGF2, and birth weight","volume":"9","author":"Montoya-Williams","year":"2018","journal-title":"J Dev Orig. Health Dis"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1096\/fj.14-255240","article-title":"Impact on offspring methylation patterns of maternal gestational diabetes mellitus and intrauterine growth restraint suggest common genes and pathways linked to subsequent type 2 diabetes risk","volume":"28","author":"Quilter","year":"2014","journal-title":"FASEB J"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpsc.2020.07.018","article-title":"Obstetric complications and brain imaging in schizophrenia: A systematic review","volume":"5","author":"Costas-Carrera","year":"2020","journal-title":"Biol Psychiatry Cogn. Neurosci Neuroimaging"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S0033291722002409","article-title":"Obstetric complications and cognition in schizophrenia: a systematic review and meta-analysis","author":"Amoretti","year":"2022","journal-title":"Psychol Med"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.rpsm.2019.12.002","article-title":"Difficulties in delivery and depressive symptomatology in schizophrenia","volume":"14","author":"Mezquida","year":"2021","journal-title":"Rev Psiquiatr. Salud Ment"},{"key":"B46","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1017\/S1461145713001053","article-title":"Course of weight gain and metabolic abnormalities in first treated episode of psychosis: The first year is a critical period for development of cardiovascular risk factors","volume":"17","author":"P\u00e9rez-Iglesias","year":"2014","journal-title":"Int J Neuropsychopharmacol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2008.09.028S0920-9964(08)00461-1","article-title":"Glucose and lipid disturbances after 1 year of antipsychotic treatment in a drug-naive population","volume":"107","author":"Perez-Iglesias","year":"2009","journal-title":"Schizophr Res"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1093\/AJE\/KWK071","article-title":"Birth weight and subsequent risk of type 2 diabetes: A meta-analysis","volume":"165","author":"Harder","year":"2007","journal-title":"Am J Epidemiol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jpeds.2019.02.041","article-title":"Preterm birth as a risk factor for metabolic syndrome and cardiovascular disease in adult life: A systematic review and meta-analysis","volume":"210","author":"Markopoulou","year":"2019","journal-title":"J Pediatr"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2010.09.017","article-title":"Validity of maternal recall of obstetric complications in mothers of patients with schizophrenia spectrum disorders and their healthy siblings","volume":"126","author":"Borrajo","year":"2011","journal-title":"Schizophr. Res"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa035698","article-title":"Relation of serial changes in childhood body-mass index to impaired glucose tolerance in young adulthood","volume":"350","author":"Bhargava","year":"2004","journal-title":"N Engl J Med"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2796.2003.01289.x","article-title":"Birth weight and cardiovascular risk factors in a cohort followed until 80 years of age: The study of men born in 1913","volume":"255","author":"Eriksson","year":"2004","journal-title":"J Intern Med"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.983792\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T06:40:04Z","timestamp":1670222404000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.983792\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,5]]},"references-count":52,"alternative-id":["10.3389\/fendo.2022.983792"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2022.983792","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,5]]},"article-number":"983792"}}